Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
J Clin Oncol · 2025-Jan-10 · PMID 39298738
Overall Survival
FIG 2. OS and EFS. (A) OS in the ITT population. (B) OS in patients who achieved dCR. (C) EFS in the ITT population assessed by actual time. The initial decreases in the Kaplan-Meier curves are due to the patients who failed to achieve initial CR/CRp within the protocol-specified timeframe or those who had induction treatment failure on the day of random assignment. (D) Prespecified exploratory subgroup analyses of EFS assessed by grouped survival analysis in the ITT population. Data are from the January 22, 2024 cutoff. CR, complete remission; CRp, CR with incomplete platelet recovery; dCR, durable complete remission; EFS, event-free survival; HR, hazard ratio; ITT, intention-to-treat; NE, not evaluable; OS, overall survival.
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 1.0000 | 0.0000 | 100.0000 | 199 | 54 |
| 1 | 2 | 0.0023 | 1.0000 | 0.1535 | 100.0000 | 200 | 54 |
| 1 | 3 | 0.0047 | 1.0000 | 0.3070 | 100.0000 | 201 | 54 |
| 1 | 4 | 0.0070 | 0.9872 | 0.4605 | 98.7179 | 202 | 56 |
| 1 | 5 | 0.0093 | 0.9744 | 0.6140 | 97.4359 | 203 | 58 |
| 1 | 6 | 0.0116 | 0.9679 | 0.7674 | 96.7949 | 204 | 59 |
| 1 | 7 | 0.0140 | 0.9615 | 0.9209 | 96.1538 | 205 | 60 |
| 1 | 8 | 0.0163 | 0.9551 | 1.0744 | 95.5128 | 206 | 61 |
| 1 | 9 | 0.0186 | 0.9359 | 1.2279 | 93.5897 | 207 | 64 |
| 1 | 10 | 0.0209 | 0.9231 | 1.3814 | 92.3077 | 208 | 66 |
| 1 | 11 | 0.0233 | 0.9103 | 1.5349 | 91.0256 | 209 | 68 |
| 1 | 12 | 0.0256 | 0.8974 | 1.6884 | 89.7436 | 210 | 70 |
| 1 | 13 | 0.0279 | 0.8718 | 1.8419 | 87.1795 | 211 | 74 |
| 1 | 14 | 0.0302 | 0.8590 | 1.9953 | 85.8974 | 212 | 76 |
| 1 | 15 | 0.0326 | 0.8590 | 2.1488 | 85.8974 | 213 | 76 |
| 1 | 16 | 0.0349 | 0.8526 | 2.3023 | 85.2564 | 214 | 77 |
| 1 | 17 | 0.0372 | 0.8462 | 2.4558 | 84.6154 | 215 | 78 |
| 1 | 18 | 0.0395 | 0.8333 | 2.6093 | 83.3333 | 216 | 80 |
| 1 | 19 | 0.0419 | 0.8205 | 2.7628 | 82.0513 | 217 | 82 |
| 1 | 20 | 0.0442 | 0.8141 | 2.9163 | 81.4103 | 218 | 83 |
| 1 | 21 | 0.0465 | 0.8077 | 3.0698 | 80.7692 | 219 | 84 |
| 1 | 22 | 0.0488 | 0.7949 | 3.2233 | 79.4872 | 220 | 86 |
| 1 | 23 | 0.0512 | 0.7885 | 3.3767 | 78.8462 | 221 | 87 |
| 1 | 24 | 0.0535 | 0.7821 | 3.5302 | 78.2051 | 222 | 88 |
| 1 | 25 | 0.0558 | 0.7692 | 3.6837 | 76.9231 | 223 | 90 |
| 1 | 26 | 0.0581 | 0.7564 | 3.8372 | 75.6410 | 224 | 92 |
| 1 | 27 | 0.0605 | 0.7372 | 3.9907 | 73.7179 | 225 | 95 |
| 1 | 28 | 0.0628 | 0.7244 | 4.1442 | 72.4359 | 226 | 97 |
| 1 | 29 | 0.0651 | 0.7115 | 4.2977 | 71.1538 | 227 | 99 |
| 1 | 30 | 0.0674 | 0.7051 | 4.4512 | 70.5128 | 228 | 100 |
| 1 | 31 | 0.0698 | 0.6923 | 4.6047 | 69.2308 | 229 | 102 |
| 1 | 32 | 0.1977 | 0.2372 | 13.0465 | 23.7179 | 284 | 173 |
| 1 | 33 | 0.2000 | 0.2372 | 13.2000 | 23.7179 | 285 | 173 |
| 1 | 34 | 0.2023 | 0.2372 | 13.3535 | 23.7179 | 286 | 173 |
| 1 | 35 | 0.2047 | 0.2308 | 13.5070 | 23.0769 | 287 | 174 |
| 1 | 36 | 0.2070 | 0.2244 | 13.6605 | 22.4359 | 288 | 175 |
| 1 | 37 | 0.2093 | 0.2244 | 13.8140 | 22.4359 | 289 | 175 |
| 1 | 38 | 0.2116 | 0.2244 | 13.9674 | 22.4359 | 290 | 175 |
| 1 | 39 | 0.2140 | 0.2244 | 14.1209 | 22.4359 | 291 | 175 |
| 1 | 40 | 0.2163 | 0.2244 | 14.2744 | 22.4359 | 292 | 175 |
| 1 | 41 | 0.2186 | 0.2244 | 14.4279 | 22.4359 | 293 | 175 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T18:16:07+00:00 |